Acute Flaccid Myelitis Associated With Enterovirus D68: A Review

Journal of Child Neurology

Volumn 34, Issue 9, 2019, Pages 511-516

  Christy, Alison ^a   Messacar, Kevin ^b  

^a Oregon Health Services Unit   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

acute flaccid myelitis; enterovirus D68; infectious disease; pediatric

Indexed keywords

ANTIVIRUS AGENT; FLUOXETINE; IMMUNOGLOBULIN; NEUTRALIZING ANTIBODY; STEROID;

BRAIN DISEASE; CEREBROSPINAL FLUID ANALYSIS; CRANIAL NEUROPATHY; DENERVATION; DIPLOPIA; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; ELECTROMYOGRAPHY; ENTEROVIRUS A71; ENTEROVIRUS D68; FACIAL DROOP; FLACCID PARALYSIS; FOLLOW UP; GUILLAIN BARRE SYNDROME; HUMAN; HYPOREFLEXIA; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MUSCLE CONTRACTION; MYELITIS; MYELOOPTIC NEUROPATHY; NERVE CONDUCTION; NEUROPATHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PLEOCYTOSIS; PNEUMONIA; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REVIEW; SEIZURE; SPINAL CORD DISEASE; SPINAL CORD ISCHEMIA; VACCINATION; VIRUS DETECTION; VIRUS LOAD; WEAKNESS; WEST NILE VIRUS; ANIMAL; CENTRAL NERVOUS SYSTEM INFECTION; COMPLICATION; ENTEROVIRUS D; ENTEROVIRUS INFECTION; NEUROMUSCULAR DISEASE;

ANIMALS; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; ENTEROVIRUS D, HUMAN; ENTEROVIRUS INFECTIONS; HUMANS; MYELITIS; NEUROMUSCULAR DISEASES;

EID: 85064931885     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073819838376     Document Type: Review

References (45)

1. Centers for Disease Control and Prevention. Non-polio enterovirus. https://www.cdc.gov/non-polio-enterovirus/about/overview.html. Published 2014.
2. Aliabadi N, Messacar K, Pastula DM. Enterovirus D68 infection in children with acute flaccid myelitis, Colorado, USA, 2014. Emerg Infect Dis. 2016;22(8):1387–1394.
3. Messacar K, Pretty K, Reno S, Dominguez SR. Continued biennial circulation of enterovirus D68 in Colorado. J Clin Virol. 2019;113:24–26.
4. Centers for Disease Control and Prevention. AFM investigation. https://www.cdc.gov/acute-flaccid-myelitis/afm-surveillance.html. Published 2018.
5. Council of State and Territorial Epidemiologists. Revision to the standardized surveillance and case definition for acute flaccid myelitis. http://c.ymcdn.com/sites/www.cste.org/resource/resmgr/2017PS/2017PSFinal/17-ID-01.pdf. Published 2018.
6. Yea C, Bitnun A, Robinson J. Longitudinal outcomes in the 2014 acute flaccid paralysis cluster in Canada. J Child Neurol. 2017;32(3):301–307.
7. Chong PF, Kira R, Mori H. Clinical features of acute flaccid myelitis temporally associated with an enterovirus D68 outbreak: results of a nationwide survey of acute flaccid paralysis in Japan, August-December 2015. Clin Infect Dis. 2018;66(5):653–664.
8. Ruggieri V, Paz MI, Peretti MG. Enterovirus D68 infection in a cluster of children with acute flaccid myelitis, Buenos Aires, Argentina, 2016. Eur J Paediatr Neurol. 2017;21(6):884–890.
9. Knoester M, Helfferich J, Poelman R. Twenty-nine cases of enterovirus-D68 associated acute flaccid myelitis in Europe 2016: a case series and epidemiologic overview. Pediatr Infect Dis J. 2019;38:16–21.
10. Messacar K, Schreiner TL, Van Haren K. Acute flaccid myelitis: a clinical review of US cases 2012–2015. Ann Neurol. 2016;80(3):326–338.
11. Sá MJ. Acute transverse myelitis: a practical reappraisal. Autoimmun Rev. 2009;9(2):128–131.
12. Illes Z, Blaabjerg M. Cerebrospinal fluid findings in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathies. Handb Clin Neurol. 2017;146:125–138.
13. Emilien D, Hugh W. Diagnostic utility of auto antibodies in inflammatory nerve disorders. J Neuromuscul Dis. 2015;2:107–112.
14. DeSena A, Graves D, Morriss MC, Greenberg BM. Transverse myelitis plus syndrome and acute disseminated encephalomyelitis plus syndrome: a case series of 5 children. JAMA Neurol. 2014;71:624–629.
15. Yiu EM, Kornberg AJ, Ryan MM, Coleman LT, Mackay MT. Acute transverse myelitis and acute disseminated encephalomyelitis in childhood: spectrum or separate entities? J Child Neurol. 2009;24:287–296.
16. Pohl D, Alper G, Van Haren K. Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome. Neurology. 2016;87(9)(suppl 2):S38–S45.
17. Mallio CA, Tombini M, Errante Y, Beomonte Zobel B, Quattrocchi CC. Progressive post-traumatic myelopathy presenting with magnetic resonance imaging snake-eye appearance. Spine J. 2013;13:830.
18. Barreras P, Fitzgerald KC, Mealy MA. Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy. Neurology. 2018;90(1):e12–e21.
19. Haq A, Wasay M. Magnetic resonance imaging in poliomyelitis. Arch Neurol. 2006;63:778.
20. Elrick MJ, Gordon-Lipkin E, Crawford TO. Clinical subpopulations in a sample of North American children diagnosed with acute flaccid myelitis, 2012-2016 [published online ahead of print November 30, 2018]. JAMA Pediatr. doi:10.1001/jamapediatrics.2018.4890.
21. Hopkins SE. Acute flaccid myelitis: etiologic challenges, diagnostic and management considerations. Curr Treat Options Neurol. 2017;19:48.
22. Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol. 2010;172:1213–1229.
23. Racaniello VR. One hundred years of poliovirus pathogenesis. Virology. 2006;344:9–16.
24. Komatsu H, Shimizu Y, Takeuchi Y, Ishiko H, Takada H. Outbreak of severe neurologic involvement associated with enterovirus 71 infection. Pediatr Neurol. 1999;20:17–23.
25. Lee KY, Lee YJ, Kim TH, Cheon DS, Nam SO. Clinico-radiological spectrum in enterovirus 71 infection involving the central nervous system in children. J Clin Neurosci. 2014;21(3):416–420.
26. Chen CY, Chang YC, Huang CC, Lui CC, Lee KW, Huang SC. Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. AJNR Am J Neuroradiol. 2001;22(1):200–205.
27. Messacar K, Burakoff A, Nix WA. Notes from the field: enterovirus a71 neurologic disease in children—Colorado, 2018. Morb Mortal Wkly Rep. 2018;67(36):1017–1018.
28. Ali M, Safriel Y, Sohi J, Llave A, Weathers S. West Nile virus infection: MR imaging findings in the nervous system. AJNR Am J Neuroradiol. 2005;26:289–297.
29. Kreuter JD, Barnes A, McCarthy JE. A fatal central nervous system enterovirus 68 infection. Arch Pathol Lab Med. 2011;135(6):793–796.
30. Compston A. Acute poliomyelitis. By F. E. Batten, MD, Cantab FRCP Lond. The Lumleian Lectures for 1916 delivered before the Royal College of Physicians. Brain 1916; 39: 115–211 [published online ahead of print April 17, 2016]. Brain. doi:10.1093/brain/aww073.
31. Leis AA, Stokic DS. Neuromuscular manifestations of West Nile virus infection. Front Neurol. 2012;3:37.
32. Hixon AM, Clarke P, Tyler KL. Evaluating treatment efficacy in a mouse model of enterovirus D68-associated paralytic myelitis. J Infect Dis. 2017;216:1245–1253.
33. Brown DM, Hixon AM, Oldfield LM. Contemporary circulating enterovirus D68 strains have acquired the capacity for viral entry and replication in human neuronal cells. MBio. 2018;9(5).
34. Greninger AL, Naccache SN, Messacar K. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort study. Lancet Infect Dis. 2015;15(6):671–682.
35. Sejvar JJ, Lopez AS, Cortese MM. Acute flaccid myelitis in the United States, August-December 2014: results of nationwide surveillance. Clin Infect Dis. 2016;63(6):737–745.
36. Messacar K, Asturias EJ, Hixon AM. Enterovirus D68 and acute flaccid myelitis—evaluating the evidence for causality. Lancet Infect Dis. 2018;18(8):e239–e247.
37. Hixon AM, Yu G, Leser JS. A mouse model of paralytic myelitis caused by enterovirus D68. PLoS Pathog. 2017;13(2):e1006199.
38. Messacar K, Schreiner TL, Maloney JA. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet. 2015;385(9978):1662–1671.
39. Ulferts R, van der Linden L, Thibaut HJ. Selective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C. Antimicrob Agents Chemother. 2013;57(4):1952–1956.
40. Tyler KL. Rationale for the evaluation of fluoxetine in the treatment of enterovirus D68-associated acute flaccid myelitis. JAMA Neurol. 2015;72:493–494.
41. Messacar K, Sillau S, Hopkins SE. Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis. Neurology. 2019;92(18):e2118–e2126.
42. Morrey JD, Wang H, Hurst BL. Causation of acute flaccid paralysis by myelitis and myositis in enterovirus-D68 infected mice deficient in interferon alphabeta/gamma receptor deficient mice. Viruses. 2018;10(1).
43. Zheng Q, Zhu R, Xu L. Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization. Nat Microbiol. 2019;4(1):124–133.
44. Dai W, Zhang C, Zhang X. A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice. Vaccine 2018;36(5):653–659.
45. Martin JA, Messacar K, Yang ML. Outcomes of Colorado children with acute flaccid myelitis at 1 year. Neurology. 2017;89(2):129–137.